Pune, India -- (SBWIRE) -- 02/13/2018 -- Global Next-Generation Sequencing (NGS) Market accounted to USD 13.51 billion by 2022 growing at a CAGR of 22.7% during the forecast period of 2017 to 2024.

Global Next Generation Sequencing (NGS) Market By Product (Instruments (Hiseq series, Miseq series, ION Torrent, SOLiD, Pacbio Rs II and Sequel system), Consumables (Sample preparation consumables, Other), Services (Sequencing services, Data management services), by Application (Diagnostics, Drug Discovery , Biomarker Discovery , Precision Medicine , Agriculture & Animal Research), by End-user (Hospitals & Clinics, Research Centers and Academic & Government Institutes, and Pharmaceutical & Biotechnology Companies), by Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Ask for Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-next-generation-sequencing-ngs-market

This report consists of below pages:


- No of pages : 350

- No of Figures: 60

- No of Tables: 220


NGS Market Definition:

Next generation sequencing is also termed as high-throughput sequencing. It is a DNA sequencing technology in which millions and billions DNA strands are sequenced. It has revolutionized genomic research, as it minimizes the requirement for fragment-cloning methods used in Sanger sequencing of genomes.

Market Competitive Analysis:

The Global Next-Generation Sequencing (NGS) Market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Global Next-Generation Sequencing (NGS) Market for global, Europe, North America, Asia Pacific and South America.

SHORT Table of Contents (TOC)

- INTRODUCTION


1.1 OVERVIEW OF THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET

1.2 CURRENCY AND PRICING

1.3 LIMITATION

1.4 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET SIZE

2.3 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET:
RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY Product

6.1 OVERVIEW

6.2 Instruments

6.3 Consumables

6.4 Services

7 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET,
BY application

7.1 OVERVIEW

7.2 Diagnostics

7.3 Drug Discovery

7.4 Biomarker Discovery

7.5 Precision Medicine

7.6 Agriculture & Animal Research

8 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY End-user

8.1 OVERVIEW

8.2 Hospitals & Clinics

8.3 Research Centers and Academic & Government Institutes

8.4 Pharmaceutical & Biotechnology Companies

9 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET,
BY GEOGRAPHY

9.1 COUNTRYWISE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

9.1.1 NORTH AMERICA

9.1.2 EUROPE

9.1.3 ASIA-PACIFIC (APAC)

9.1.4 LATIN AMERICA

9.1.5 MIDDLE EAST AND AFRICA

9.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

10 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET:
COMPETITIVE LANDSCAPE

10.1. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET:
COMPANY SHARE ANALYSIS

10.2. NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE ANALYSIS

10.3. EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET:
COMPANY SHARE ANALYSIS

10.4. APAC NEXT GENERATION SEQUENCING (NGS) MARKET:
COMPANY SHARE ANALYSIS

10.5. MEA NEXT GENERATION SEQUENCING (NGS) MARKET:
COMPANY SHARE ANALYSIS

10.6. SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE ANALYSIS

10.7. MERGERS & ACQUISITIONS

10.8. NEW PRODUCT DEVELOPMENT & APPROVALS

10.9. EXPANSIONS

10.10. REGULATORY CHANGES

10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

11 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET,
COMPANY PROFILES

11.1 QIAGEN

11.2 BGI

11.3 Oxford Nanopore Technologies

11.4 F. Hoffmann-La Roche Ltd

11.5 PerkinElmer Inc.

11.6 GATC Biotech AG

11.7 Agilent Technologies

11.8 Macrogen, Inc.

11.9 Bio-Rad Laboratories, Inc.

11.10 DNASTAR, Inc.,

11.11 Biomatters Limited.

11.12 Partek Incorporated

12 APPENDIX

13 ABOUT DATA BRIDGE MARKET RESEARCH

Request for Detail TOC @ http://databridgemarketresearch.com/toc/?dbmr=global-next-generation-sequencing-ngs-market

Market Segmentation:

By Technology :- Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing.

By Application:- Diagnostics, Drug Discovery, Biomarker Discovery, Precision Medicine, Agriculture and Animal Research, Reproductive Health, Personalized Medicine, Oncology, Clinical Investigation, Forensics,. HLA typing/Immune System Monitoring, Metagenomics, Epidemiology.

By End Users:- Hospitals & Healthcare institutions, Biotech & Pharma firms, Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Clinical Research.

By Geography:- North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The major countries of the market are U.S., Canada, Mexico, Germany,France, Italy, Spain, India, Japan, China, Australia, South Korea, Taiwan, Brazil, Turkey, Suadi Arabia and South Africa among others.

North America is dominating the market followed by the Europe.

Major Market Drivers and Restraints:


- Advanced technology in NGS platforms and increased applications of NGS.

- Increased in adoption of NGS among research laboratories and academic institutes.

- Efficient speed, cost, and accuracy of the technology.

- Drug discovery applications in NGS technology are some of the factors which drives the market.

- R&D investments are another factor to grow the market.

- Lack of skilled technicians.

- Accuracy and uniformity concerns in diagnostics testing limits the growth of market.

- Interpretation of complex data and issues regarding storage of sequencing data hinders the market.

- Legal and ethical issues are the challenge in the growing market.

- Emerging markets are proving the new opportunities in the growth of the market.

- Application of NGS in precision medicines & Biomarker discovery.


Questions? We'll Put You On The Right Path Request Analyst Call @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-next-generation-sequencing-ngs-market

(NGS) Major Market Competitors:


- Illumina, Inc.,

- Thermo Fisher Scientific Inc.,

- Pacific Biosciences of California, Inc.,

- QIAGEN,

- BGI,

- Oxford Nanopore Technologies,

- PerkinElmer, Inc.,

- GATC Biotech AG,

- Agilent Technologies,

- Hoffmann-La Roche Ltd,

- Macrogen, Inc.,

- Eurofins Scientific,

- Biomatters Limited,

- Genomatix GmbH,

- PierianDx, Myriad Genetics, Inc.,

- Partek Incorporated,

- DNASTAR, Inc.,

- New England Biolabs

- among others.


Read more about the Global Next Generation Sequencing Market @ http://databridgemarketresearch.com/reports/global-next-generation-sequencing-ngs-market/

About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Vishal Dixit

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com